Hypothesis

We propose that hormetic stressors extend lifespan not by activating KDM5/KDM6 demethylases but by transiently inhibiting their Fe(II)- and α‑ketoglutarate‑dependent activity, which creates H3K4me3/H3K27me3 bivalent chromatin at stress‑response genes. The longevity benefit depends on the capacity of cells to reactivate KDM5/KDM6 during the recovery phase, resolving bivalency and restoring a stable transcriptional program. With age, NAD+ decline and mitochondrial dysfunction impair this reactivation, leaving bivalency unresolved and converting a protective poised state into a maladaptive lock‑in.

Mechanistic Basis

• KDM5 and KDM6 families require Fe(II) and α‑KG; oxidative stress depletes α‑KG and raises 2‑HG, directly inhibiting catalysis ([1][3]).
• Hypoxia and EMT show that KDM6A inhibition generates adaptive bivalent domains that are resolved when the enzyme returns ([2][4][5]).
• KDM5B sustains mitochondrial genome stability, linking its activity to cellular energy state ([6]).
• We add that the NAD+-dependent sirtuin SIRT1 regulates intracellular α‑KG production via deacetylation of glutaminase; hormetic bouts raise NAD+, transiently inhibiting KDMs, while recovery‑phase NAD+ fall permits SIRT1‑driven α‑KG restoration and KDM reactivation.

Testable Predictions

1. In young mice, acute hormetic stressors (e.g., 2 h fasting, 40 °C heat shock, 500 µM H₂O₂) will cause a rapid drop in KDM5B/KDM6A enzymatic activity in liver nuclei, accompanied by increased H3K4me3/H3K27me3 at promoters of Hsp70, Sod2, and Pgc1α.
2. Within 4–6 h post‑stress, activity will rebound above baseline, and bivalent marks will resolve to either active (H3K4me3) or repressed (H3K27me3) states.
3. In aged mice (24 mo), the same stressor will produce a similar initial activity drop but fail to show the rebound; bivalency will persist ≥12 h.
4. Pharmacological NAD+ boosters (NR) administered during recovery will restore KDM reactivation and bivalency resolution in aged mice, rescuing the hormetic lifespan extension.

Experimental Approach

• Use liver isolates from young (3 mo) and old (24 mo) C57BL/6 mice.
• Apply stressors ex vivo or in vivo; harvest nuclei at 0, 1, 3, 6, 12 h.
• Measure KDM5B/KDM6A activity via coupled fluorometric assay assessing demethylation of peptide substrates.
• Perform ChIP‑seq for H3K4me3 and H3K27me3; quantify bivalency at target promoters.
• Monitor NAD+/NADH, α‑KG, and 2‑HG levels by LC‑MS.
• In a rescue cohort, give NR (400 mg/kg) during recovery and repeat assays.

Potential Outcomes and Interpretation

If predictions hold, the data will show that hormesis works through a stress‑induced off‑switch for KDM5/6, not an on‑switch, and that aging disrupts the reactivation step. This reframes the longevity literature: interventions that boost NAD+ or α‑KG during recovery may be as important as the stressor itself. Failure to observe the activity rebound in aged tissue would falsify the hypothesis that KDM reactivation is required for hormetic benefit, pushing focus onto alternative mechanisms.

References (inline)

• [1] Hypoxia inactivates KDM6A via α‑KG depletion and 2‑HG accumulation (https://www.science.org/doi/10.1126/science.aaw1026)
• [2] EMT stress suppresses KDM6A, forming bivalent domains resolved at MET (https://www.oncotarget.com/article/19214/)
• [3] H₂O₂‑induced chromatin remodeling sensitive to EZH2 inhibition (GSK126) (https://doi.org/10.1101/2023.12.29.573604)
• [4] Tumor hypoxia sustains KDM6A inhibition to drive progression (https://pmc.ncbi.nlm.nih.gov/articles/PMC8688854/)
• [5] Transient KDM6A loss during EMT creates adaptive bivalency (https://pmc.ncbi.nlm.nih.gov/articles/PMC5630352/)
• [6] KDM5 proteins maintain mitochondrial biology and genome stability (https://pmc.ncbi.nlm.nih.gov/articles/PMC10651110/)